Ingevity Completes Acquisition of Georgia-Pacific’s Pine Chemicals Business
Ingevity Corporation said it bought Georgia-Pacific’s pine chemicals business for $310 million in cash.
Ingevity said it expects to derive approximately $11 million in net synergies, which are expected to be attained through lower logistics costs, manufacturing optimization among the combined three chemicals plants and leveraged procurement costs.
In purchasing the pine chemicals business, Ingevity has acquired the pine chemicals-related assets at Georgia-Pacific’s Crossett, Ark., plant, saleable inventory, customer lists and the book of business, as well as various patents and trade names associated with acquired product lines.
Separately, Ingevity has entered into a 20-year, market-based crude tall oil (CTO) supply contract with certain of Georgia-Pacific’s paper mill operations.
“This acquisition will provide a stronger platform from which we will accelerate the profitable growth of our Performance Chemicals segment,” said Michael Wilson, Ingevity president and CEO. “With the addition of Georgia-Pacific’s broader technologies and product platforms, we will add scale and competitiveness to this segment, and create significant value for our shareholders.”
Wilson noted that the acquisition will complement existing businesses, with limited customer overlap.
Georgia-Pacific’s pine chemicals business manufactures and sells pine-based tall oil fatty acids, tall oil rosin, and tall oil rosin esters used in adhesives, cleaners, paints and other coatings, inks, metalworking, mining, oilfield, packaging and rubber processing.
“We anticipate the integration process to run efficiently: Our management team has a history of successfully integrating acquisitions, and experience in operating co-located manufacturing facilities. As we move through this process, we remain deeply committed to ensuring that customers continue to receive excellent products and services,” said Mike Smith, president of Ingevity’s Performance Chemicals segment.
2026-09-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Ingevity Plans to Sell Industrial Specialties and CTO Refinery
-
Ingevity Will Closes Its DeRidder Factory
-
P&G launched the first major group acquisition in 2023
-
Rainbow acquires S.A. to accelerate market expansion in the EU
-
China丨Grand Holding acquired Microbe with ¥ 830 million to lay out for biopesticide industry chain
-
China丨Maxunitech acquired Shijie, became the tops in Sulfentrazone, Flumioxazin technical production capacity
-
China丨Flagchem acquired 100% equity of Suke to improve its formulation capacity
-
Valued at $110 Million! Zai Lab Partner Entasis Acquired
-
Tuoqiu Shares Acquired 51% Equity of Liaoning Futuo for 30 Million Yuan
-
14.3 Billion Acquisition! Where Will The Chemical Industry Leader 'Transform' in The Future?
Recommend Reading
-
Borealis Commits Over €100 Million to New PP Compounds Line in Austria
-
IFF to Establish Scent Creative Center in Mumbai
-
Evonik to Spin Off Infrastructure Operations into New Services Company SYNEQT
-
BASF, Sinopec Forge Green Alliance to Power Nanjing Site with Certified Bio-Methane
-
Europe’s Chemical Industry in the Ice Age: Profits Evaporating, Plants Shutting Down, Capital Fleeing—A Systemic Collapse Is Underway
-
Business Society’s BDO Market Outlook on August 21, 2026: Strong Consolidation
-
BDO Market Trends Show Narrow Upside Movement
-
Spot supply continues to be tight, acrylonitrile market shows a slight rebound
-
Cost-side Support Boosts Polyester Staple Fiber Prices, Stopping the Decline and Rebounding
-
Bearish Factors Persist, Adipic Acid Prices in China Decline
- Hot Searches
- dimethyl carbonate price
- aluminium carbide
- ammounium sulfate
- glp-3 retatrutide buy online usa
- benzodiazepine for sale
- polydimethylsiloxane
- retatrutide for sale online cheap
- best place to buy retatrutide peptides online
- hydroquinone powder
- calcined alumina suppliers
- buy nandrolone decanoate
- triz peptide